0001693011-18-000004.txt : 20181121 0001693011-18-000004.hdr.sgml : 20181121 20181121162242 ACCESSION NUMBER: 0001693011-18-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181121 DATE AS OF CHANGE: 20181121 EFFECTIVENESS DATE: 20181121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inozyme Pharma, Inc. CENTRAL INDEX KEY: 0001693011 IRS NUMBER: 475129768 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-326389 FILM NUMBER: 181198442 BUSINESS ADDRESS: STREET 1: 280 SUMMER STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 857-330-4340 MAIL ADDRESS: STREET 1: 280 SUMMER STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Inozyme Pharma, LLC DATE OF NAME CHANGE: 20161222 D 1 primary_doc.xml X0708 D LIVE 0001693011 Inozyme Pharma, Inc. 280 Summer Street 5th Floor Boston MA MASSACHUSETTS 02210 857-330-4340 DELAWARE Inozyme Pharma, LLC Corporation true 2015 Axel Bolte 280 Summer Street 5th Floor Boston MA MASSACHUSETTS 02210 Executive Officer Director Joseph Schlessinger 280 Summer Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Reinaldo Diaz 280 Summer Street 5th FLoor Boston MA MASSACHUSETTS 02210 Director Edward Mathers 280 Summer Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Martin Edwards 280 Summer Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Rob Hopfner 280 Summer Street 5th Floor Boston MA MASSACHUSETTS 02210 Director Pharmaceuticals Decline to Disclose 06b false 2018-11-09 true true false 0 10699996 10699996 0 false 5 0 0 0 false Inozyme Pharma, Inc. /s/ Axel Bolte Axel Bolte Chief Executive Officer 2018-11-21